VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Syndax Pharmaceuticals, Inc. (SNDX) Total Return Calculator with Dividends Reinvested

Syndax Pharmaceuticals, Inc.

Popular:

The total return for Syndax Pharmaceuticals, Inc. (SNDX) stock is +105.61% over the past 12 months. So far it's down 3.57% this year. The 5-year total return is +28.05%, meaning $10,000 invested in SNDX stock 5 years ago would be worth $12,805 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in SNDX 1 year ago, it would be worth $18,656 today — you'd have gained $8,656.

With Dividends Reinvested$18,656+86.56%

Price Only (No DRIP)$18,656+86.56%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in SNDX

1Y$20,561+$10,561 (+105.6%)105.6% CAGR

3Y$10,123+$123 (+1.2%)0.4% CAGR

5Y$12,805+$2,805 (+28.1%)5.1% CAGR

10Y$14,344+$4,344 (+43.4%)3.7% CAGR

15Y$17,117+$7,117 (+71.2%)3.6% CAGR

20Y$17,117+$7,117 (+71.2%)2.7% CAGR

30Y$17,117+$7,117 (+71.2%)1.8% CAGR

Syndax Pharmaceuticals, Inc. did not pay dividends during this period. Total return = price return.

Loading SNDX total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-3.57%	—	-3.57%	—	$9,643
1Y	+105.61%	105.61%	+105.61%	—	$20,561
3Y	+1.23%	0.41%	+1.23%	—	$10,123
5Y	+28.05%	5.07%	+28.05%	—	$12,805
10Y	+43.44%	3.67%	+43.44%	—	$14,344
15Y	+71.17%	3.65%	+71.17%	—	$17,117
20Y	+71.17%	2.72%	+71.17%	—	$17,117
30Y	+71.17%	1.81%	+71.17%	—	$17,117

Risk & Highlights

Best Year+153.59%2020

Worst Year-49.26%2018

Max Drawdown-36.83%2026-04-02 → 2026-05-01

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	+1.92%	+1.92%	—	+0.41%	+1.5pp
2025	+49.22%	+49.22%	—	+16.64%	+32.6pp
2024	-39.52%	-39.52%	—	+24.00%	-63.5pp
2023	-15.59%	-15.59%	—	+24.81%	-40.4pp
2022	+14.90%	+14.90%	—	-19.95%	+34.8pp

SNDX outperformed the S&P 500 by 75.23pp over the past year (+105.61% vs +30.37%).

Loading summary...

SNDX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
SNDXSyndax Pharmaceuticals, Inc.	$1.8B	-16.6%	-3.6%	+105.6%	—	+1.2%	+28.1%	+43.4%
KYMRKymera Therapeutics, Inc.	$6.9B	-0.6%	+16.3%	+190.7%	—	+205.1%	+92.1%	+154.4%
IMVTImmunovant, Inc.	$5.5B	+10.6%	+5.1%	+96.1%	—	+40.9%	+62.4%	+173.6%
RVMDRevolution Medicines, Inc.	$30.3B	+48.0%	+80.3%	+278.4%	—	+483.1%	+382.1%	+393.1%
TGTXTG Therapeutics, Inc.	$6.9B	+28.9%	+46.9%	+23.5%	—	+30.0%	+7.0%	+436.5%
PRAXPraxis Precision Medicines, Inc.	$9.6B	+8.7%	+16.4%	+775.0%	—	+1976.5%	-20.8%	-20.1%
VERAVera Therapeutics, Inc.	$2.6B	-10.3%	-26.2%	+58.6%	—	+374.6%	+212.0%	+212.0%
IOVAIovance Biotherapeutics, Inc.	$1.3B	+6.9%	+40.9%	+13.4%	—	-49.9%	-87.6%	-34.3%
FATEFate Therapeutics, Inc.	$280M	+111.3%	+145.5%	+143.0%	—	-55.4%	-96.8%	+40.5%
MGNXMacroGenics, Inc.	$186M	-12.2%	+82.6%	+97.3%	—	-59.4%	-90.8%	-84.4%
PTCTPTC Therapeutics, Inc.	$5.3B	-7.3%	-16.0%	+58.2%	—	+16.1%	+60.3%	+733.2%

Compare:SNDX vs KYMR SNDX vs IMVT SNDX vs RVMD SNDX vs KYMR vs IMVT

About SNDX Dividend Returns

Syndax Pharmaceuticals, Inc. (SNDX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of SNDX over the past year?

Syndax Pharmaceuticals, Inc. (SNDX) delivered a return of 105.61% over the past year. Since SNDX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in SNDX be worth today?

A $10,000 investment in Syndax Pharmaceuticals, Inc. one year ago would be worth $20,561 today, representing a gain of $10,561.

Q3Does SNDX pay dividends?

Syndax Pharmaceuticals, Inc. (SNDX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For SNDX, the total return equals the price-only return.

Q4Did SNDX beat the S&P 500?

Yes, Syndax Pharmaceuticals, Inc. (SNDX) outperformed the S&P 500 by 75.23 percentage points over the past year. SNDX delivered a total return of 105.61%, compared to the S&P 500's 30.37%. This 75.23pp alpha means investors in SNDX earned more than a passive S&P 500 index fund.

Q5What is SNDX's worst drawdown?

Syndax Pharmaceuticals, Inc. (SNDX) experienced a maximum drawdown of -36.83% over the past year, declining from its peak on 2026-04-02 to its trough on 2026-05-01. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is SNDX's long-term total return over 10, 20, or 30 years?

Here are Syndax Pharmaceuticals, Inc. (SNDX)'s long-term returns with dividends reinvested. Over 10 years, the total return is 43.4% (3.7% CAGR) — $10,000 would have grown to $14,344. Over 20 years: 71.2% total return (2.7% CAGR) — $10,000 → $17,117. Over 30 years: 71.2% total return (1.8% CAGR) — $10,000 → $17,117. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was SNDX's best and worst year?

Syndax Pharmaceuticals, Inc.'s best calendar year was 2020 with a total return of 153.6%. Its worst year was 2018 with a total return of -49.3%. This range shows the volatility investors should expect — the difference between the best and worst year is 202.9 percentage points.